Elevated cardiac troponin I in a 9-week-old infant

Area of Science:

• Pediatric Cardiology
• Biochemical Markers
• Congenital Heart Defects

Background:

• Myocardial ischemia is rarely suspected in pediatric patients presenting with congestive heart failure, unlike in adults.
• Cardiac troponin is a specific biomarker for myocardial damage in both pediatric and adult populations.
• Routine cardiac troponin testing is not standard practice for children at risk of myocardial damage.

Observation:

• A case study of an infant with a complex congenital heart defect and congestive heart failure is presented.
• This infant exhibited elevated cardiac troponin levels, indicating myocardial damage.
• This highlights a potential diagnostic gap in pediatric cardiology.

Findings:

• Elevated cardiac troponin levels in infants with congenital heart defects and heart failure signify myocardial damage.
• Infants with elevated cardiac troponin are at increased risk for cardiac dysrhythmias.
• Worsening cardiac function is also a significant risk associated with elevated troponin in this population.

Implications:

• Cardiac troponin evaluation should be considered for infants at risk for myocardial damage.
• Early identification of elevated cardiac troponin can lead to closer monitoring and timely therapeutic interventions.
• This approach may improve outcomes for infants with congenital heart disease and myocardial injury.